GHK-Cu (Copper Peptide) – 10 Vials (CAS: 89030-95-5)

Price range: $289.00 through $316.00

GHK-Cu (Copper Tripeptide-1) is an endogenous tripeptide (Gly-His-Lys) complexed with copper(II) ions. This high-purity lyophilized powder is widely researched for its roles in tissue remodeling, collagen synthesis, anti-inflammatory signaling, and antioxidant defense. Supplied for laboratory research use only.

Description

GHK-Cu is a copper-binding tripeptide with the sequence Glycyl-L-Histidyl-L-Lysine. It forms a stable complex with copper(II) ions with an affinity similar to the copper transport site on albumin. GHK-Cu is endogenous in human plasma, saliva, and urine, but its concentration declines significantly with age. This product is supplied as a sterile lyophilized powder and is intended strictly for research purposes only. It is NOT for human or veterinary consumption.

 

Key Research Focus

GHK-Cu has been investigated in preclinical research exploring its roles in:

  • Tissue Remodeling and Wound Healing: GHK-Cu activates a broad spectrum of remodeling-related processes, including chemoattraction of repair cells (macrophages, mast cells, capillary cells), anti-inflammatory actions, and increased protein synthesis of collagen, elastin, and metalloproteinases. In a mouse scald model, GHK-Cu-liposomes accelerated wound healing by promoting cell proliferation and angiogenesis, with wound healing time shortened to 14 days.
  • Collagen and Extracellular Matrix Synthesis: GHK-Cu stimulates collagen synthesis in fibroblasts and increases the synthesis and deposition of type I collagen and glycosaminoglycans . It also modulates matrix metalloproteinase-2 (MMP-2) expression and increases secretion of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2), indicating a role in extracellular matrix remodeling.
  • Anti-Inflammatory Activity: GHK-Cu decreases TNF-alpha-dependent IL-6 secretion in normal human dermal fibroblasts . In a bleomycin-induced pulmonary fibrosis model, GHK-Cu attenuated inflammation and fibrosis by downregulating NF-κB and activating Nrf2 expression, and by suppressing TGF-β1/Smad2/3 signaling.
  • Keratinocyte Proliferation and Stem Cell Maintenance: Copper-GHK increases keratinocyte proliferation and enhances p63 positivity—a putative stem cell marker of the skin—suggesting it promotes the survival of basal stem cells in the skin.
  • Antioxidant Defense: GHK-Cu possesses antioxidant activity due to its ability to supply copper for superoxide dismutase (SOD) and its capacity to block iron (Fe²⁺) release during injury.

 

Recent Clinical Research

A Phase 2, randomized, double-blind, vehicle-controlled clinical trial (NCT07437586, “CuHeal”) is evaluating a topical GHK-Cu gel (0.1% w/w) for accelerating re-epithelialization of standardized acute skin wounds in healthy adults. The primary objective is to determine whether topical GHK-Cu gel reduces time to complete re-epithelialization versus vehicle gel. Wounds are assessed over 21 days, with scar quality evaluated at 12 weeks.

 

Product Specifications

  • Form: Lyophilized Powder (Sterile)
  • Purity: ≥98% (HPLC Verified)
  • Molecular Formula: C₁₄H₂₄N₆O₄·Cu (as complex)
  • Molecular Weight: ~340.9 Da (peptide) + Cu
  • CAS Number: 89030-95-5
  • Sequence: Gly-His-Lys
  • Storage: Store at -20°C (freezer) for long-term stability. Protect from light.
  • Solubility: Highly hydrophilic (log D between -2.38 and -2.49 at pH 4.5–7.4); soluble in water or sterile buffer for laboratory use.
  • Disclaimer: This product is a chemical reagent for research purposes only. It is NOT for human or animal consumption, diagnostic, or therapeutic use.

 

Why Choose GHK-Cu?

GHK-Cu is one of the most extensively studied copper peptides in tissue remodeling research, with a well-characterized mechanism involving copper delivery, gene expression modulation, and extracellular matrix regulation. Its demonstrated effects on collagen synthesis, angiogenesis, inflammation, and antioxidant defense make it a valuable tool for researchers investigating wound healing, skin biology, and fibrotic disease models. The availability of an active Phase 2 clinical trial provides a translational reference point for understanding its wound-healing potential.

Additional information

Grams

50mg, 100mg

Disclaimer: Supplied strictly as a high-purity chemical reagent for laboratory research and development use only. Not for human or animal consumption.

Our Products